ID18739A - Kombinasi-kombinasi antiviral - Google Patents

Kombinasi-kombinasi antiviral

Info

Publication number
ID18739A
ID18739A IDP972146A ID972146A ID18739A ID 18739 A ID18739 A ID 18739A ID P972146 A IDP972146 A ID P972146A ID 972146 A ID972146 A ID 972146A ID 18739 A ID18739 A ID 18739A
Authority
ID
Indonesia
Prior art keywords
antiviral combinations
antiviral
combinations
Prior art date
Application number
IDP972146A
Other languages
English (en)
Inventor
Martha Heider St Clair
David Walter Barry
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614024.9A external-priority patent/GB9614024D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID18739A publication Critical patent/ID18739A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IDP972146A 1996-06-25 1997-06-23 Kombinasi-kombinasi antiviral ID18739A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2217896P 1996-06-25 1996-06-25
GBGB9614024.9A GB9614024D0 (en) 1996-07-04 1996-07-04 Antiviral therapeutic combinations

Publications (1)

Publication Number Publication Date
ID18739A true ID18739A (id) 1998-05-07

Family

ID=26309631

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972146A ID18739A (id) 1996-06-25 1997-06-23 Kombinasi-kombinasi antiviral

Country Status (26)

Country Link
US (1) US6486136B1 (id)
EP (1) EP0910386B1 (id)
KR (1) KR20000022225A (id)
CN (1) CN1306430A (id)
AP (1) AP9801418A0 (id)
AT (1) ATE230267T1 (id)
AU (1) AU723877C (id)
BR (1) BR9709951A (id)
CA (1) CA2262765A1 (id)
CO (1) CO4910137A1 (id)
CZ (1) CZ429398A3 (id)
DE (1) DE69718168T2 (id)
EA (1) EA001457B1 (id)
ES (1) ES2189964T3 (id)
HU (1) HUP9903098A3 (id)
ID (1) ID18739A (id)
IL (1) IL127350A0 (id)
IS (1) IS4913A (id)
NO (1) NO986035L (id)
NZ (1) NZ333098A (id)
PE (1) PE87398A1 (id)
PL (1) PL330791A1 (id)
TR (1) TR199802703T2 (id)
WO (1) WO1997049410A1 (id)
YU (1) YU58498A (id)
ZA (1) ZA975565B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
EP1019056A1 (en) * 1997-05-17 2000-07-19 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
BR9911457A (pt) * 1998-06-24 2001-12-11 Univ Emory Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
GB9307013D0 (en) * 1993-04-02 1993-05-26 Wellcome Found Therapeutic combinations
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5646180A (en) * 1995-12-05 1997-07-08 Vertex Pharmaceuticals Incorporated Treatment of the CNS effects of HIV

Also Published As

Publication number Publication date
ATE230267T1 (de) 2003-01-15
EA199801046A1 (ru) 1999-08-26
HUP9903098A2 (hu) 1999-12-28
NZ333098A (en) 2000-08-25
AU723877B2 (en) 2000-09-07
CA2262765A1 (en) 1997-12-31
CZ429398A3 (cs) 1999-05-12
AP9801418A0 (en) 1998-12-31
EA001457B1 (ru) 2001-04-23
AU3262697A (en) 1998-01-14
ES2189964T3 (es) 2003-07-16
TR199802703T2 (xx) 1999-03-22
CO4910137A1 (es) 2000-04-24
NO986035L (no) 1999-02-23
HU9903098D0 (en) 1999-10-28
CN1306430A (zh) 2001-08-01
KR20000022225A (ko) 2000-04-25
ZA975565B (en) 1998-12-23
PL330791A1 (en) 1999-06-07
NO986035D0 (no) 1998-12-22
HUP9903098A3 (en) 2000-01-28
EP0910386A1 (en) 1999-04-28
WO1997049410A1 (en) 1997-12-31
DE69718168D1 (de) 2003-02-06
AU723877C (en) 2001-08-23
YU58498A (en) 1999-11-22
US6486136B1 (en) 2002-11-26
BR9709951A (pt) 1999-08-10
IL127350A0 (en) 1999-10-28
DE69718168T2 (de) 2003-10-23
IS4913A (is) 1998-11-30
PE87398A1 (es) 1999-01-15
EP0910386B1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
BR9709643A (pt) Compostos antivirais
ATE208395T1 (de) Thiophenopyrimidine
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
NO963385L (no) Böyebegrenser
ID19490A (id) Kombinasi-kombinasi antiviral
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
BR9709432A (pt) Composto antivirais
BR9709528A (pt) Compostos antivirais
NO20011358L (no) Antivirale kombinasjoner
DE69721955D1 (de) Hohltretlagereinheit
ID15956A (id) Kombinasi-kombinasi herbisida
LV12033A (lv) Mebelu izgatavosanas panemiens
SE9600614D0 (sv) Antiviral compounds
SE9602566D0 (sv) Antiviral compounds
SE9604179D0 (sv) Antiviral compounds
ATE267568T1 (de) Epithese
BR7600260U (pt) Multi-morsa
BR7601310U (pt) Microlivro
BR9600914A (pt) Lipodecantador
BR7603492U (pt) Protemilk
BR7603147U (pt) Simborgueup
BR7602320U (pt) Supedânea
BR9603698A (pt) Hidro-escova dorso-lombar
BR9604479A (pt) Gongorremo